{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:45:06Z","timestamp":1783694706363,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Danon disease (DD) is an exceptionally uncommon X-linked dominant lysosomal glycogen storage disorder characterized by pronounced ventricular hypertrophy and cardiac insufficiency. The timely identification of cardiac impairment in individuals with DD holds significant clinical importance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a case of Danon Disease in a three-generation pedigree from Anhui Province, China. Clinical features and laboratory data were collected and analyzed for a 16-year-old male proband (III-1) and two affected female family members (II-2 and II-3). The proband exhibited Wolf-Parkinson-White syndrome, hypertrophic cardiomyopathy, abnormal cognitive function, and muscle weakness. Gene sequencing confirmed a mutation (c.963G\u2009&gt;\u2009A) in the LAMP-2 gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with DD may present both dilated and hypertrophic cardiomyopathy. Comprehensive myocardial tissue characterization by MRI plays a key role in the diagnosis of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03356-y","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T18:02:23Z","timestamp":1691776943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical manifestations and MRI features of Danon disease: a case series"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"3356_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnen\/64.6.513","volume":"64","author":"K Sugie","year":"2005","unstructured":"Sugie K, Noguchi S, Kozuka Y, Arikawa-Hirasawa E, Tanaka M, Yan C, et al. Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol. 2005;64:513\u201322. https:\/\/doi.org\/10.1093\/jnen\/64.6.513.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3356_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35022604","volume":"406","author":"I Nishino","year":"2000","unstructured":"Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;406:906\u201310. https:\/\/doi.org\/10.1038\/35022604.","journal-title":"Nature"},{"issue":"3","key":"3356_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/heartjnl-2019-314856","volume":"106","author":"JR Arnold","year":"2020","unstructured":"Arnold JR, McCann GP. Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist. Heart. 2020;106(3):174\u201381. https:\/\/doi.org\/10.1136\/heartjnl-2019-314856.","journal-title":"Heart"},{"key":"3356_CR4","doi-asserted-by":"publisher","unstructured":"Nakamori S. Dohi, Native T1 mapping and extracellular volume mapping for the Assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC. Cardiovascular imaging. (2018) 11(1):48\u201359. doi: https:\/\/doi.org\/10.1016\/j.jcmg.2017.04.006.","DOI":"10.1016\/j.jcmg.2017.04.006"},{"key":"3356_CR5","doi-asserted-by":"publisher","first-page":"eaax1744","DOI":"10.1126\/scitranslmed.aax1744","volume":"535","author":"AM Manso","year":"2020","unstructured":"Manso AM, Hashem SI, Nelson BC, Gault E, Soto-Hermida A, Villarruel E, et al. Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease. SCI TRANSL MED. 2020;535:eaax1744. https:\/\/doi.org\/10.1126\/scitranslmed.aax1744.","journal-title":"SCI TRANSL MED"},{"key":"3356_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.115.019847","volume":"134","author":"KM Ng","year":"2016","unstructured":"Ng KM, Mok PY, Butler AW, Ho JC, Choi SW, Lee YK, et al. Amelioration of X-Linked related autophagy failure in Danon Disease with DNA methylation inhibitor. Circulation. 2016;134:1373\u201389. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019847.","journal-title":"Circulation"},{"key":"3356_CR7","doi-asserted-by":"publisher","first-page":"790917","DOI":"10.3389\/fcvm.2022.790917","volume":"9","author":"J Xie","year":"2022","unstructured":"Xie J, Liu Y, Wei X, et al. Relationship between fragmented QRS Complex and Left Ventricular fibrosis and function in patients with Danon Disease. Front Cardiovasc Med. 2022;9:790917. https:\/\/doi.org\/10.3389\/fcvm.2022.790917.","journal-title":"Front Cardiovasc Med"},{"key":"3356_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1253\/circj.cj-08-0241","volume":"73","author":"N Dougu","year":"2009","unstructured":"Dougu N, Joho S, Shan L, Shida T, Matsuki A, Uese K, et al. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Circ J. 2009;73:376\u201380. https:\/\/doi.org\/10.1253\/circj.cj-08-0241.","journal-title":"Circ J"},{"key":"3356_CR9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1212\/wnl.58.12.1773","volume":"58","author":"K Sugie","year":"2002","unstructured":"Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology. 2002;58:1773\u20138. https:\/\/doi.org\/10.1212\/wnl.58.12.1773.","journal-title":"Neurology"},{"key":"3356_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.125.2.231","volume":"125","author":"DF Schorderet","year":"2007","unstructured":"Schorderet DF, Cottet S, Lobrinus JA, Borruat FX, Balmer A, Munier FL. Retinopathy in Danon disease. Arch Ophthalmol. 2007;125:231\u20136. https:\/\/doi.org\/10.1001\/archopht.125.2.231.","journal-title":"Arch Ophthalmol"},{"key":"3356_CR11","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Sainz \u00c1, Salazar-Mendiguch\u00eda J, Garc\u00eda-\u00c1lvarez A, Campuzano Larrea O, L\u00f3pez-Garrido M, Garc\u00eda-Guereta L et al. Clinical findings and prognosis of Danon Disease. An analysis of the spanish Multicenter Danon Registry. Rev Esp Cardiol (Engl Ed). (2019) 72:479\u201386. doi: https:\/\/doi.org\/10.1016\/j.rec.2018.04.035.","DOI":"10.1016\/j.rec.2018.04.035"},{"key":"3356_CR12","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3892\/etm.2019.7777","volume":"18","author":"S Guo","year":"2019","unstructured":"Guo S, Zhou L, Wang R, Lv Z, Xu H, Han B, et al. Danon disease: two patients with atrial fibrillation in a single family and review of the literature. Exp Ther Med. 2019;18:1527\u201332. https:\/\/doi.org\/10.3892\/etm.2019.7777.","journal-title":"Exp Ther Med"},{"key":"3356_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cge.12724","volume":"90","author":"H Cetin","year":"2016","unstructured":"Cetin H, W\u00f6hrer A, Rittelmeyer I, Gencik M, Zulehner G, Zimprich F, et al. The c.65-2A > G splice site mutation is associated with a mild phenotype in Danon disease due to the transcription of normal LAMP2 mRNA. Clin Genet. 2016;90:366\u201371. https:\/\/doi.org\/10.1111\/cge.12724.","journal-title":"Clin Genet"},{"key":"3356_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1148\/radiol.2021203996","volume":"299","author":"X Wei","year":"2021","unstructured":"Wei X, Zhao L, Xie J, Liu Y, Du Z, Zhong X, et al. Cardiac phenotype characterization at MRI in patients with Danon Disease: a retrospective Multicenter Case Series. Radiology. 2021;299:303\u201310. https:\/\/doi.org\/10.1148\/radiol.2021203996.","journal-title":"Radiology"},{"key":"3356_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10038-007-0184-8","volume":"52","author":"MRG Taylor","year":"2007","unstructured":"Taylor MRG, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, et al. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007;52:830\u20135. https:\/\/doi.org\/10.1007\/s10038-007-0184-8.","journal-title":"J Hum Genet"},{"key":"3356_CR16","doi-asserted-by":"publisher","first-page":"e003117","DOI":"10.1161\/CIRCGEN.120.003117","volume":"13","author":"D Lotan","year":"2020","unstructured":"Lotan D, Salazar-Mendiguch\u00eda J, Mogensen J, Rathore F, Anastasakis A, Kaski J, et al. Clinical Profile of Cardiac involvement in Danon Disease: a Multicenter European Registry. Circ Genom Precis Med. 2020;13:e003117. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003117.","journal-title":"Circ Genom Precis Med"},{"key":"3356_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jcmg.2020.08.011","volume":"14","author":"M Rigolli","year":"2021","unstructured":"Rigolli M, Kahn AM, Brambatti M, Contijoch FJ, Adler ED. Cardiac magnetic resonance imaging in Danon Disease Cardiomyopathy. JACC Cardiovasc Imaging. 2021;14:514\u20136. https:\/\/doi.org\/10.1016\/j.jcmg.2020.08.011.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3356_CR18","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1002\/mgg3.561","volume":"7","author":"N Zhou","year":"2019","unstructured":"Zhou N, Cui J, Zhao W, Jiang Y, Zhu W, Tang L, et al. A family with Danon disease caused by a splice site mutation in LAMP2 that generates a truncated protein. Mol Genet Genomic Med. 2019;7:e561. https:\/\/doi.org\/10.1002\/mgg3.561.","journal-title":"Mol Genet Genomic Med"},{"key":"3356_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-015-0192-3","volume":"17","author":"P P\u00f6yh\u00f6nen","year":"2015","unstructured":"P\u00f6yh\u00f6nen P, Hiippala A, Ollila L, Kaasalainen T, H\u00e4nninen H, Heli\u00f6 T, et al. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations. J Cardiovasc Magn Reson. 2015;17:89. https:\/\/doi.org\/10.1186\/s12968-015-0192-3.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03356-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:11:14Z","timestamp":1700597474000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03356-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3356"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03356-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by Fuyang People\u2019s Hospital Ethics Committee (2021-56). The patients\/participants provided their written informed consent to participate in this study. All procedures were conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in the declarations section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"397"}}